Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy
- 43 Downloads
Measurement of amino acids in brain tissue obtained at autopsy from cirrhotic patients dying in hepatic coma revealed a threefold increase in glutamine and a concomitant decrease in brain glutamate. The GABA levels were found to be unaltered. Studies using an animal model of portal-systemic encephalopathy gave similar results. Glutamic acid decarboxylase (GAD) activities were within normal limits, both in the brains of cirrhotic patients and portocaval-shunted rats. A previous study reported normal [3H]GABA binding to synaptic membrane preparations from cerebral cortex in these animals. Taken together, these findings suggest that cerebral GABA function is not impaired in hepatic encephalopathy associated with chronic liver disease and portal-systemic shunting. On the other hand, there is evidence to suggest that the releasable pool ofglutamate may be depleted in brain in hepatic encephalopathy. Data consistent with this hypothesis include: (i) Reduction in the evoked release of endogenous glutamate by superfusion of hippocampal slices with pathophysiological levels of ammonia; (ii) ammonia-induced reduction of glutamatergic neurotransmission; and (iii) an increase in the number of [3H]glutamate binding sites in synaptic membrane preparations from hyperammonemia rats and from rats with portocaval shunts. Such neurochemical changes may be of pathophysiological significance in hepatic encephalopathy.
Index EntriesHepatic encephalopathy portocaval anastomosis GABA glutamate glutamic acid decarboxylase
Unable to display preview. Download preview PDF.
- Butterworth R. F. (1985) Double-isotope dansyl microassay for cerebral amino acids inNeuromethods (Boulton A. A., Baker G. B., and Wood J. D., eds.) vol. 3, pp. 81–95, Humana, Clifton, NJ.Google Scholar
- Butterworth R. F. and Giguère J. F. (1984) Region-selective glutamine changes in the CNS in relation to function in experimental subacute hepatic encephalopathy, inAdvances in Hepatic Encephalopathy and Urea Cycle Diseases (Kleinberger G., Ferenci P., Riederer P., and Thaler H., eds.) pp. 394–401, Karger, Basel, Switzerland.Google Scholar
- Butterworth R. F., Giguère J. F., Samii A. and Bergeron M. (1986) Regional glutamate changes in experimental hepatic encephalopathy.Trans. Am. Soc. Neurochem. 17, 242.Google Scholar
- Cremer J. E., Heath D. F., Teal H. M., Woods M. S., and Cavanagh J. B. (1975) Some dynamic aspects of brain metabolism in rats given a portocaval anastomosis.Neuropath. Appl. Neurobiol. 3, 292–311.Google Scholar
- DeArmond S. J., Fusco M. M., and Dewey M. M. (1976) Structure of the human brain, 2nd Ed., Oxford University, New York, NY.Google Scholar
- Fonnum F. (1985) Determination of transmitter amino acid turnover, inNeuromethods, vol. 3 (Boulton A. A., Baker G. B., and Wood J. D., eds.), pp. 201–237 Humana, Clifton, NJ.Google Scholar
- Plum F. and Hindfelt B. (1976) The neurological complications of liver disease, inHandbook of Clinical Neurology (Vinken P. H. and Bruyn G. W., eds.), vol. 27, pp. 349–377, American Elsevier, New York, NY.Google Scholar
- Zanchin G., Maggioni F., Salassa D., and Vassanelli P. (1984) GABA and dopamine receptors after chronic porta-caval shunt in the rat, inAdvances in Hepatic Encephalopathy and Urea Cycle Diseases (Kleinberger G., Ferenci P., Riederer P., and Thaler H., eds.), pp. 360–367, Karger, Basel, Switzerland.Google Scholar
- Zeneroli M. L., Baraldi M., and Ventura E. (1984) γ-Aminobutyric acid receptors in experimental hepatic encephalopathy, inHepatic Encephalopathy in Chronic Liver Failure (Capocaccia L., Fischer J. E., and Rossi-Fanelli F., eds.), pp. 25–40, Plenum, New York, NY.Google Scholar